KYOWA HAKKO USA, INC. is the North America sales office for KYOWA HAKKO BIO CO., LTD., and distributor for Kyowa Pharma Chemical Co. As an international health ingredients manufacturer and a world leader in the development, manufacturing and marketing of nutraceuticals, pharmaceuticals and food products, Kyowa is a pioneer in the development and application of fermentation technology and maintains an ongoing commitment to research, developing innovative new products and quality management.

Get the fall 2019 issue of AminoScope. Kyowa Hakko Bio's news from Around the Globe

Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Lumistor® L-Hydroxyproline, Setria® Glutathione, Pantesin® Pantethine, and VELOX® L-Citrulline and L-Arginine.

News

  • Kyowa Hakko Announces Scientific-Breakthrough for Eye Health - EYEMUSE™ Enters the U.S. Market

    April 6, 2021

    Kyowa Hakko, global leaders in the research, manufacturing and purification of high-quality health ingredients, is thrilled to introduce a new perspective on eye health. Its breakthrough clinically-researched eye health ingredient, EYEMUSE™, is entering the U.S. market, becoming the first heat-treated probiotic strain for healthy eye function, discovered by Kyowa Hakko’s parent-company Kirin Holdings Co., Ltd. View news »

  • Kyowa Hakko Launches Setria® Glutathione "Breathe" Campaign

    February 18, 2021

    Kyowa Hakko, global leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products, is introducing its new “Breathe” brand campaign featuring Setria® Glutathione, a patented glutathione ingredient that supports respiratory and immune health*. View news »